A reduced level of calnexin (10.25 ± 1.63 vs. 20.42 ± 3.97 in healthy controls) was found to characterise the B cell compartment from CLL subjects (Figure 6A). The gene discussed is CANX; the disease is B-cell chronic lymphocytic leukemia.